Midatech appoints Rolf Stahel as Chairman
Craig Cook appointed as Chief Operating Officer and Chief Medical Officer
Midatech Ltd. announced the appointments of Rolf Stahel as Chairman and Craig Cook as Chief Operating Officer (COO) and Chief Medical Officer (CMO), significantly strengthening the Company’s Board and senior management team.
Rolf Stahel has more than 40 years of experience in the pharmaceutical industry, of which 20 years were spent at CEO and Board level in public and private life science companies across Europe, the US and India. He was Chief Executive Officer at Shire between 1994 and 2003, during which time he led the company’s listing on the London Stock Exchange in 1996 and development into a global specialty biopharmaceutical company with a market capitalization of over $3 billion. He joined Shire from Wellcome plc (now GSK) where he spent 27 years in positions of increasing seniority.
Mr Stahel is currently the Non-executive Chairman of Connexios Life Sciences Pvt Ltd, an Indian drug discovery company focused on new drugs for the treatment of metabolic diseases. He has also been Non-executive Chairman of EUSA Pharma, Cosmo Pharmaceuticals SpA, PowderMed Ltd and Newron Pharmaceuticals SpA.
Dr Craig Cook has over 15 years’ of experience in senior management, business development and clinical product development roles in the pharma, biomedical and high technology sectors. During this time he has established a successful track record of growing early stage companies into profitable international businesses.
Dr Cook joins Midatech from SpaceCode Technologies, an early-stage provider of IT solutions to the healthcare industry, which he co-founded in 2005. Prior to that, Dr Cook held senior management positions at Novartis and Serono International (now Merck Serono). Dr Cook is an advisor to Ippon Capital, the Swiss private equity firm specializing in the healthcare sector that led the latest investment round in Midatech.
Other news from the department people
